While being highly significant, the degree of Vpu-mediated downregulation in these β-TrCP-depleted cells was reduced compared to control cells (62 to 79% residual levels, Figure 7C ).
← all excerpts
β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release.
1
—
—